Etiological involvement of oncogenic human papillomavirus in tonsillar squamous cell carcinomas lacking retinoblastoma cell cycle control

Cancer Research

Volumn 58, Issue 1, 1998, Pages 5-13

  Andl, Thomas ^a   Kahn, Tomas ^c   Pfuhl, Andreas ^a   Nicola, Teodora ^c   Erber, Ralf ^a   Conradt, Christian ^b   Klein, Wolfgang ^a   Helbig, Matthias ^a   Dietz, Andreas ^a   Weidauer, Hagen ^a   Bosch, Franz X ^a,d  

^a Molekularbiologisches Labor   (Germany)

^b Abteilung Medizinische Physik   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

RETINOBLASTOMA PROTEIN;

ARTICLE; CARCINOGENESIS; CHROMOSOME ABERRATION; CONTROLLED STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; TONSIL CARCINOMA; TUMOR SUPPRESSOR GENE;

EID: 0031964379     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Cann, C. I., Fried, M. P., and Rothman, K. J. Epidemiology of squamous cell cancer of the head and neck. Otolaryngol. Clin., 18: 1-22, 1985.
2. Field, J. K. Oncogenes and tumor-suppressor genes in squamous cell carcinoma of the head and neck. Eur. J. Cancer, 28B: 67-76, 1992.
3. Beijersbergen, R. L., and Bernards, R. Cell cycle regulation by the retinoblastoma family of growth inhibitory proteins. Biochim. Biophys. Acta, 1287: 103-120, 1996.
4. La Thangue, N. B. DRTF1/E2F: an expanding family of heterodimeric transcription factors implicated in cell cycle control. Trends Biochem. Sci., 19: 108-114, 1994.
5. Serrano, M., Hannon, G. J., and Beach, D. A. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature (Lond.), 366: 704-707, 1993.
6. Bates, S., Parry, D., Bonetta, L., Voudsen, K., Dickson, C., and Peters, G. Absence of cyclin D1/cdk complexes in cells lacking functional retinoblastoma protein. Oncogene, 9: 1633-1640, 1994.
7. Parry, D., Bates, S., Mann, D. J., and Peters, G. Lack of cyclin D-cdk complexes in Rb-negative cells correlates with high levels of p16INK4/MTS1 tumor suppressor gene product. EMBO J., 14: 503-511, 1995.
8. Symonds, H., Krall, L., Remington, L., Saenz-Robles, M., Jacks, T., and Van Dyke, T. p53-dependent apoptosis suppresses tumor growth and progression in vivo. Cell, 78: 703-711, 1994.
9. Dyson, N., Howley, P. M., Münger, K., and Harlow, E. The human papillomavirus 16 E7 protein is able to bind to the retinoblastoma gene product. Science (Washington DC), 243: 934-937, 1989.
10. Lukas, J., Müller, H., Bartkova, J., Spitkovsky, D., Kjerulff, A. A., Jansen-Dürr, P., Strauss, M., and Bartek, J. DNA tumor virus oncoproteins and retinoblastoma gene mutations share the ability to relieve the cell's requirement for cyclin D1 function in G1. J. Cell Biol., 125: 625-638, 1994.
11. zur Hausen, H. Papillomavirus infections - a major cause of human cancers. Biochim. Biophys. Acta, 1288: F55-F78, 1996.
12. Kahn, T., Turazza, E., Ojeda, R., Bercovich, A., Stremlau, A., Lichter, P., Poustka, A., Grinstein, S., and zur Hausen, H. Integration of human papillomavirus type 6a DNA in a tonsillar carcinoma: chromosomal localization and nucleotide sequence of genomic target region. Cancer Res., 54: 1305-1312, 1994.
13. Paz, I. B., Cook, N., Odom-Maryom, T., Xie, Y., and Wilczynski, S. P. Human papillomavirus (HPV) in head and neck cancer: an association of HPV16 with squamous cell carcinoma of the Waldeyer's tonsillar ring. Cancer (Phila.), 79: 595-604, 1997.
14. Haraf, D. J., Nodzenski, E., Brachman, D., Mick, R., Montag, A., Graves, D., Vokes, E. E., and Weichselbaum, R. R. Human papillomavirus and p53 in head and neck cancer: clinical correlates and survival. Clin. Cancer Res., 2: 755-762, 1996.
15. Snijders, P. J., Steenbergen, R. D., Top, B., Scott, S. D., Meijer, C. J., and Walboomers, J. M. Analysis of p53 status in tonsillar carcinomas associated with human papillomavirus. J. Gen. Virol., 75: 2769-2775, 1994.
16. Yoo, G. H., Xu, H. J., Brennan, J. A., Westra, W., Hruban, R. H., Koch, W., Benedict, W. F., and Sidransky, D. Infrequent inactivation of the retinoblastoma gene despite frequent loss of chromosome 13q in head and neck squamous cell carcinoma. Cancer Res., 54: 4603-4606, 1994.
17. Motokura, T., Bloom, T., Kim, H. G., Juppner, H., Ruderman, J. V., Kronenberg, H. M., and Arnold, A. A novel cyclin encoded by bcl1-linked candidate oncogene. Nature (Lond.), 350: 512-515, 1991.
18. Nees, M., Homann, N., Discher, H., Andl, T., Enders, C., Herold-Mende, C., Schuhmann, A., and Bosch, F. X. Expression of mutated p53 occurs in tumor-distant epithelia of head and neck cancer patients: a possible molecular basis for the development of multiple tumors. Cancer Res., 53: 4189-4196, 1993.
19. Soder A. I., Hopman A. H. N., Ramaeker, F. C. S., Conradt, C., and Bosch, F. X. Distinct non-random patterns of chromosomal aberrations in the progression of squamous cell carcinomas of the head and neck. Cancer Res., 55: 5030-5037, 1995.
20. CIP1/WAF1 protein accumulation in head and neck cancer. Int. J. Cancer, 74: 383-389, 1997.
21. Gyapay, G., Morissette, J., Vignal, A., Dib, C., Fizames, C., Millasseau, P., Marc, S., Bernardi, G., Lathrap, M., and Weissenbach, J. The 1993-1994 Genethon human genetic linkage map. Nat. Genet., 7: 246-339, 1994.
22. Saiki, R., Scharf, S., Faloona, F., Mullis, K. B., Horn, G. T., and Erlich, H. A. Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for the diagnosis of sickle cell anemia. Science (Washington DC), 230: 1350-1354, 1985.
23. Van den Brule, A. J., Claas, E. C., du Maine, M., Melchers, W. J., Helmerhorst, T., Quint, W. G., Lindeman, J., Meijer, C. J., and Walboomers, J. M. Use of anticontamination primers in the polymerase chain reaction for the detection of human papillomavirus genotypes in cervical scrapes and biopsies. J. Med. Virol., 29: 20-27, 1989.
24. Resnick, R. M., Cornelissen, M. T., Wright, D. K., Eichinger, G. H., Fox, H. S., Scheggert, J., and Manos, M. M. Detection and typing of HPV in archival cervical cancer specimens by DNA amplification with consensus primers. J. Natl. Cancer Inst., 82: 1477-1484, 1990.
25. Jones, D. L., and Münger, K. Analysis of the p53-mediated G1 growth arrest pathway in cells expressing the human papillomavirus type 16 E7 oncoprotein. J. Virol., 71: 2905-2912, 1997.
26. Peterson, S. R., Gadbois, D. M., Bradbury, E. M., and Kraemer, P. M. Immortalization of human fibroblasts by SV40 large T antigen results in the reduction of cyclin D1 expression and subunit association with proliferating cell nuclear antigen and WAF1. Cancer Res., 55: 4651-4657, 1995.
27. Kelley, M. J., Otterson, G. A., Kaye, F. J., Popescu, N. C., Johonson, B. E., and Dipaolo, J. A. CDKN2 in HPV-positive and HPV-negative cervical carcinoma cell lines. Int. J. Cancer, 63: 226-230, 1995.
28. Boyer, S. N., Wazer, D. E., and Band, V. E7 protein of human papillomavirus 16 induces degradation of retinoblastoma protein through the ubiquitin-proteasome pathway. Cancer Res., 56: 4620-4624, 1996.
29. Scheffner, M., Werness, B. A., Huibregtse, J. M., Levine, A. J., and Howley, P. M. The E6 oncoprotein encoded by human papillomavirus type 16 and 18 promotes the degradation of p53. Cell, 63: 1129-1136, 1990.
30. Aas, T., Borrensen, A. L., Geisler, S., Smith-Sorensen, B., Johonson, H., Varhaug, J. E., Akslen, L. A., and Lonning, P. E. Specific p53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients. Nat. Med., 2:811-814, 1996.
31. Almasan, A., Yin, Y., Kelly, R. E., Lee, E. Y-H. P., Bradley, A., Li, W., Bertino, J. R., and Wahl, G. M. Deficiency of retinoblastoma protein leads to inappropriate S-phase entry, activation of E2F-responsive genes, and apoptosis. Proc. Natl. Acad. Sci. USA, 92: 5436-5440, 1995.
32. Mietz, J. A., Unger, T., Huibregtse, J. M., and Howley, P. M. The transcriptional transactivation function of wild-type p53 is inhibited by SV40 large T antigen and by HPV16 E6 oncoprotein. EMBO J., 11: 5013-5020, 1992.
33. Butz, K., Shahabeddin, L., Geisen, C., Spitkovsky, D., Ullmann, A., and Hoppe-Seyler, F. Functional p53 protein in human papillomavirus-positive cancer cells. Oncogene, 10: 927-936, 1995.
34. Butz, K., Geisen, C., Ullmann, A., Spitkovsky, D., and Hoppe-Seyler, F. Cellular responses of HPV-positive cancer cells to genotoxic anti-cancer agents: repression of E6/E7-oncogene expression and induction of apoptosis. Int. J. Cancer, 68: 56-513, 1996.
35. Demers, G. W., Foster, S. A., Halbert, C. L., and Galloway, D. A. Growth arrest by induction of p53 in DNA damaged keratinocytes is bypassed by human papillomavirus 16 E7. Proc. Natl. Acad. Sci. USA, 91: 4382-4386, 1994.
36. Reznikoff, C. A., Belair, C., Savelieva, E., Zhai, Y., Pfeiffer, K., Yeager, T., Thompson, K. J., DeVries, S., Bindley, C., Newton, M. A., Sekhon, G., and Waldman, F. Long-term genome stability and minimal genotypic and phenotypic alteration in HPV16 E7-, but not E6-, immortalized human urothelial cells. Genes Dev., 8: 2227-2240, 1994.